The Science of Healing: A New Age In The Fight Against Prostate Cancer
SLUCare nuclear medicine specialists liken their approach to treating cancer to “a magic bullet.” On the next episode of The Science of Healing, see how theranostic therapy uses one radioactive drug to locate the cancer, followed by a second radioactive drug that destroys the tumor with precision. This approach has been approved for prostate cancer as well as neuroendocrine tumors with hopes that this can be used for other types of cancers as well. Don’t miss it! The Science of Healing: Nuclear Medicine, aired Thursday, Jan. 20 on KMOV-TV 4. More information online at www.slucare.edu Theranostic Nuclear Medicine involves the use of radioactive components to image tumors followed with the use of special ionizing radiation to destroy the tumor. 00:00 Start 00:46 What is Nuclear Medicine & Theranostics? 03:08 The Prostate Cancer Clinical Trials 04:45 John's Story 08:16 Positive Clinical Trial Results 11:31 Alonzo's Story 15:13 Very Specialized Treatment Facilities 18:00 Helping Cancer Patients at the VA 22:44 Using this therapy for other cancers 24:43 The Future of treatment To schedule an appointment with a SLUCare physician, please call (314) 977-4440. SLUCare Physician Group is a patient-centered network of more than 500 health care providers on staff at Saint Louis University School of Medicine. As part of an academic medical practice, SLUCare physicians are experts in their respective fields, providing specialty care for even the most complex medical conditions. SLUCare physicians practice in 47 different hospitals and clinics throughout the St. Louis region, making high-quality, advanced care convenient for you and your family.
